TY - JOUR
AU - 
TI - An anti-C3b(i) mAb enhances complement activation, C3b(i) deposition, and killing of CD20+ cells by rituximab
JF - Blood
DO - 10.1182/blood-2002-03-0876
DA - 2003-02-01
UR - https://www.deepdyve.com/lp/unpaywall/an-anti-c3b-i-mab-enhances-complement-activation-c3b-i-deposition-and-T050UGSEXM
DP - DeepDyve
ER -